Catabasis Pharmaceuticals Inc (CATB):企業の財務・戦略的SWOT分析

◆英語タイトル:Catabasis Pharmaceuticals Inc (CATB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH135764FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and rationally targeted (SMART) Linker drug discovery platform for rare diseases, among others. Its product candidate edasalonexent CAT-1004, currently under Phase 3 trial, is an oral small molecule intended for the treatment of Duchenne muscular dystrophy. CAT-5571, an activator of autophagy and the company’s lead product under preclinical stage, is an oral small molecule for the treatment of cystic fibrosis. The company’s CAT-4001 is used for the treatment of neurodegenerative diseases such as Friedreich’s ataxia and amyotrophic lateral sclerosis (ALS). Catabasis Pharmaceuticals is headquartered in Cambridge, Massachusetts, the US.

Catabasis Pharmaceuticals Inc Key Recent Developments

Mar 11,2021: Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
Mar 02,2021: Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
Jan 29,2021: Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.
Nov 12,2020: Catabasis Pharmaceuticals reports third quarter 2020 financial results and provides a corporate update
Sep 21,2020: Catabasis Pharmaceuticals names Noah Clauser Chief Financial Officer

This comprehensive SWOT profile of Catabasis Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Catabasis Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Catabasis Pharmaceuticals Inc – Key Information
Catabasis Pharmaceuticals Inc – Overview
Catabasis Pharmaceuticals Inc – Key Employees
Catabasis Pharmaceuticals Inc – Key Employee Biographies
Catabasis Pharmaceuticals Inc – Key Operational Heads
Catabasis Pharmaceuticals Inc – Major Products and Services
Catabasis Pharmaceuticals Inc – History
Catabasis Pharmaceuticals Inc – Company Statement
Catabasis Pharmaceuticals Inc – Locations And Subsidiaries
Catabasis Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Catabasis Pharmaceuticals Inc – Business Description
Catabasis Pharmaceuticals Inc – Corporate Strategy
Catabasis Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Catabasis Pharmaceuticals Inc – Strengths
Catabasis Pharmaceuticals Inc – Weaknesses
Catabasis Pharmaceuticals Inc – Opportunities
Catabasis Pharmaceuticals Inc – Threats
Catabasis Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Catabasis Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Catabasis Pharmaceuticals Inc, Key Information
Catabasis Pharmaceuticals Inc, Key Ratios
Catabasis Pharmaceuticals Inc, Share Data
Catabasis Pharmaceuticals Inc, Major Products and Services
Catabasis Pharmaceuticals Inc, History
Catabasis Pharmaceuticals Inc, Key Employees
Catabasis Pharmaceuticals Inc, Key Employee Biographies
Catabasis Pharmaceuticals Inc, Key Operational Heads
Catabasis Pharmaceuticals Inc, Other Locations
Catabasis Pharmaceuticals Inc, Subsidiaries
Catabasis Pharmaceuticals Inc, Key Competitors
Catabasis Pharmaceuticals Inc, SWOT Analysis
Catabasis Pharmaceuticals Inc, Ratios based on current share price
Catabasis Pharmaceuticals Inc, Annual Ratios
Catabasis Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Catabasis Pharmaceuticals Inc (CATB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SenesTech Inc (SNES):企業の財務・戦略的SWOT分析
    SenesTech Inc (SNES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Dixons Carphone plc:企業のM&A・事業提携・投資動向
    Dixons Carphone plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dixons Carphone plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Taiwan Cogeneration Corp (8926):企業の財務・戦略的SWOT分析
    Summary Taiwan Cogeneration Corp (Taiwan Cogeneration) is a power company that offers power and electrical energy generation and cogeneration services. The corporation provides services such as construction, investment, operation, and management of power and energy generation cogeneration plants in …
  • Charoen Pokphand Foods Public Co Ltd (CPF):企業の戦略的SWOT分析
    Charoen Pokphand Foods Public Co Ltd (CPF) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • SIGA Technologies Inc (SIGA):企業の財務・戦略的SWOT分析
    Summary SIGA Technologies Inc (SIGA) is a health security service provider. The company develops and commercialise solutions for serious unmet medical needs and bio threats. It offers antiviral drug to treat smallpox disease. SIGA offers product such as TPOXX. The company’s Tecovirimat is combined w …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • UCL Business PLC:製薬・医療:M&Aディール及び事業提携情報
    Summary UCL Business PLC (UCLB), a subsidiary of University College London is a technology transfer company that supports and markets research and innovations. The company offers licensing technologies and innovations, creates shared risk joint venture businesses, and promotes and supports the trans …
  • Occidental Petroleum Corp (OXY):石油・ガス:M&Aディール及び事業提携情報
    Summary Occidental Petroleum Corp (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream and marketing; and chemicals business. The oil and gas business explores for, develops and produces oil, …
  • Allegra Orthopaedics Ltd (AMT):企業の財務・戦略的SWOT分析
    Allegra Orthopaedics Ltd (AMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Investcorp Bank BSc (INVCORP):企業の財務・戦略的SWOT分析
    Investcorp Bank BSc (INVCORP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Baxter International Inc.:企業の戦略・SWOT・財務情報
    Baxter International Inc. - Strategy, SWOT and Corporate Finance Report Summary Baxter International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Burmeister & Wain Scandinavian Contractor AS-エネルギー分野:企業M&A・提携分析
    Summary Burmeister & Wain Scandinavian Contractor A/S (BWSC), a subsidiary of MESCO Denmark A/S, is a provider of tailor-made turnkey power plant solutions. It develops, operates and undertakes contracts for medium to large-scale power plants. The company handles projects for conventional fossil-fue …
  • Inmarsat Plc (ISAT):企業の財務・戦略的SWOT分析
    Inmarsat Plc (ISAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Macro Enterprises Inc (MCR):企業の財務・戦略的SWOT分析
    Summary Macro Enterprises Inc (Macro Enterprises) is an oil and gas company that offers pipeline and facility construction and maintenance services. The company provides gathering, processing, transmission, storage and distribution of pipeline systems. It offers fabrication and installation of pipin …
  • Maxim’s Caterers Limited:戦略・SWOT・企業財務分析
    Maxim's Caterers Limited - Strategy, SWOT and Corporate Finance Report Summary Maxim's Caterers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Energy Fuels Inc (EFR):企業の財務・戦略的SWOT分析
    Energy Fuels Inc (EFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Information Analysis Inc (IAIC):企業の財務・戦略的SWOT分析
    Summary Information Analysis Inc (IAI) is a technology company that offers technical solutions. The company offers IT services such as legacy mainframe modernization, database conversion and migration, electronic forms conversion, ebusiness and web based solutions, integrated tablet and mobile appli …
  • Peters Surgical:医療機器:M&Aディール及び事業提携情報
    Summary Peters Surgical (Peters), a subsidiary of Eurazeo SA, is a medical device company that designs, manufactures and distributes surgical products. The company offers products such as catheters, sutures, surgical glue, cardiac ring, single use instrument and accessories for surgical procedures. …
  • Titan Cement Company Sa
    Titan Cement Company Sa - Strategy, SWOT and Corporate Finance Report Summary Titan Cement Company Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BioCorRx Inc (BICX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioCorRx Inc (BioCorRx), formerly Fresh Start Private Management Inc, is a healthcare solution provider. The company provides alcoholism and opioid addiction treatment program for use in rehabilitation and treatment centers. It distributes and licenses BioCorRx recovery program, a medication …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆